Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India

References

• Sharma A, Nagalli S. 2020. Chronic liver disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available at .nih.gov/books/NBK554597/, accessed April 21, 2020.
   Google Scholar
• Arvaniti V, D’Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246–56. 1256 e1241-1245. doi:10.1053/j.gastro.2010.06.019.
   PubMed Web of Science ®Google Scholar
• Hernaez R, Sola E, Moreau R, Gines P. Acute-on-chronic liver failure: an update. Gut. 2017;66:541–53. doi:10.1136/gutjnl-2016-312670.
   PubMed Web of Science ®Google Scholar
• GBD Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. doi:10.1016/S0140-6736(18)32279-7.
   PubMed Web of Science ®Google Scholar
• GBD. DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2017;2018(392):1859–922. doi:10.1016/S0140-6736(18)32335-3.
   Google Scholar
• GBD. Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2017;2018(392):1736–88. doi:10.1016/S0140-6736(18)32203-7.
   Google Scholar
• Manzarbeitia C Liver transplantation. Available at https://emedicine.medscape.com/article/431783-print, accessed April 21, 2020.
   Google Scholar
• Ghassemi S, Garcia-Tsao G. Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:77–93. doi:10.1016/j.bpg.2006.07.004.
   PubMed Web of Science ®Google Scholar
• Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26–42. doi:10.1055/s-2008-1040319.
   PubMed Web of Science ®Google Scholar
• Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis. 2000;182:526–33. doi:10.1086/315742.
   PubMed Web of Science ®Google Scholar
• Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102:1510–17. doi:10.1111/j.1572-0241.2007.01286.x.
   PubMed Web of Science ®Google Scholar
• Irvine KM, Ratnasekera I, Powell EE, Hume DA. Causes and consequences of innate immune dysfunction in cirrhosis. Front Immunol. 2019;10:293. doi:10.3389/fimmu.2019.00293.
   PubMed Web of Science ®Google Scholar
• Reiss G, Keeffe EB. Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther. 2004;19:715–27. doi:10.1111/j.1365-2036.2004.01906.x.
   PubMed Web of Science ®Google Scholar
• Keeffe EB. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc. 2006;117:227–37. discussion 237-228.
   PubMedGoogle Scholar
• Cooksley WG. What did we learn from the Shanghai hepatitis A epidemic? J Viral Hepat. 2000;7(Suppl 1):1–3. doi:10.1046/j.1365-2893.2000.00021.x.
   PubMedGoogle Scholar
• Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353–90. doi:10.1007/s12072-019-09946-3.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO position paper on hepatitis A vaccines – june 2012. Wkly Epidemiol Rec 2012;87:261–76.
   PubMedGoogle Scholar
• Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286–90. doi:10.1056/NEJM199801293380503.
   PubMed Web of Science ®Google Scholar
• Lefilliatre P, Villeneuve JP. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health. 2000;91:168–70. doi:10.1007/BF03404264.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule for ages 19 years or older, United States, 2020. Available at https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html, accessed April 21, 2020.
   Google Scholar
• National Health Service (NHS). NHS vaccinations and when to have them: extra vaccines for at-risk people. Available at https://www.nhs.uk/conditions/vaccinations/nhs-vaccinations-and-when-to-have-them/, accessed June 9, 2020.
   Google Scholar
• Verma R, Hepatitis KP. A vaccine should receive priority in National Immunization Schedule in India. Hum Vaccin Immunother. 2012;8:1132–34. doi:10.4161/hv.20475.
   PubMed Web of Science ®Google Scholar
• Mukherjee PS, Vishnubhatla S, Amarapurkar DN, Das K, Sood A, Chawla YK, Eapen CE, Boddu P, Thomas V, Varshney S, et al. Etiology and mode of presentation of chronic liver diseases in India: a multi centric study. PLoS One. 2017;12:e0187033. doi:10.1371/journal.pone.0187033.
   PubMed Web of Science ®Google Scholar
• Choudhuri G, Chaudhari S, Pawar D, Roy DS. Etiological patterns, liver fibrosis stages and prescribing patterns of hepato-protective agents in Indian patients with chronic liver disease. J Assoc Physicians India. 2018;66:58–63.
   PubMedGoogle Scholar
• Joshi N, Rao S, Kumar A, Patil S, Hepatitis RS. A vaccination in chronic liver disease: is it really required in a tropical country like India? Indian J Med Microbiol. 2007;25:137–39. doi:10.4103/0255-0857.32720.
   PubMedGoogle Scholar
• Hussain Z, Das BC, Husain SA, Murthy NS, Kar P. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. J Gastroenterol Hepatol. 2006;21:689–93. doi:10.1111/j.1440-1746.2006.04232.x.
   PubMedGoogle Scholar
• Ramachandran J, Eapen CE, Kang G, Abraham P, Hubert DD, Kurian G, Hephzibah J, Mukhopadhya A, Chandy GM. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol. 2004;19:134–38. doi:10.1111/j.1440-1746.2004.03188.x.
   PubMed Web of Science ®Google Scholar
• Anand AC, Nagpal AK, Seth AK, Dhot PS. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India? J Assoc Physicians India. 2004;52:785–87.
   PubMedGoogle Scholar
• Shalimar SV, Singh SP, Duseja A, Shukla A, Eapen CE, Kumar D, Pandey G, Venkataraman J, Puri P, Narayanswami K, et al. Acute-on-chronic liver failure in India: the Indian national association for study of the liver consortium experience. J Gastroenterol Hepatol. 2016;31(10):1742–49. doi:10.1111/jgh.13340.
   Web of Science ®Google Scholar
• Acharya SK, Batra Y, Saraya A, Hazari S, Dixit R, Kaur K, Bhatkal B, Ojha B, Panda SK. Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India. Natl Med J India. 2002;15:267–68.
   PubMed Web of Science ®Google Scholar
• Xavier S, Anish K. Is hepatitis A vaccination necessary in Indian patients with cirrhosis of liver? Indian J Gastroenterol. 2003;22:54–55.
   PubMedGoogle Scholar
• Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29:392–98. doi:10.1111/j.1478-3231.2008.01887.x.
   PubMed Web of Science ®Google Scholar
• Shah AS, Amarapurkar DN. Natural history of cirrhosis of liver after first decompensation: a prospective study in India. J Clin Exp Hepatol. 2018;8:50–57. doi:10.1016/j.jceh.2017.06.001.
   PubMed Web of Science ®Google Scholar
• Kumar A, Gupta V, Arora A. Most liver related deaths in India are caused by alcohol: an audit of liver mortality from tertiary care center in North India [abstract]. Clin Gastroenterol Hepatol. 2017;15:e37. doi:10.1016/j.cgh.2016.09.092.
   PubMedGoogle Scholar
• Ray G. Trends of chronic liver disease in a tertiary care referral hospital in Eastern India. Indian J Public Health. 2014;58:186–94. doi:10.4103/0019-557X.138630.
   PubMedGoogle Scholar
• Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. 2016;60:26–33. doi:10.4103/0019-557X.177295.
   PubMedGoogle Scholar
• Duseja A, Najmy S, Sachdev S, Pal A, Sharma RR, Marwah N, Chawla Y. High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India. JGH Open. 2019;3:133–39. doi:10.1002/jgh3.12117.
   PubMed Web of Science ®Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386:1546–55. doi:10.1016/S0140-6736(15)61412-X.
   Google Scholar
• Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2019;34:321–29. doi:10.1111/jgh.14466.
   PubMed Web of Science ®Google Scholar
• Worldometer. India population. Available at https://www.worldometers.info/world-population/india-population/, accessed June 9, 2020.
   Google Scholar
• Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, Jia J, Tian Q, Aggarwal R, Muljono DH, et al. Liver diseases in the Asia-pacific region: a Lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2020;5:167–228. doi:10.1016/S2468-1253(19)30342-5.
   PubMed Web of Science ®Google Scholar
• GBD. Cirrhosis collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2017;2020(5):245–66. doi:10.1016/S2468-1253(19)30349-8.
   Google Scholar
• Bhattacharyya M, Barman NN, Goswami B. Survey of alcohol-related cirrhosis at a tertiary care center in North East India. Indian J Gastroenterol. 2016;35:167–72. doi:10.1007/s12664-016-0651-2.
   PubMed Web of Science ®Google Scholar
• Pati GK, Singh A, Misra B, Misra D, Das HS, Panda C, Singh SP. Acute-on-chronic liver failure (ACLF) in coastal Eastern India: “a single-center experience”. J Clin Exp Hepatol. 2016;6:26–32. doi:10.1016/j.jceh.2015.08.002.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Sharma M, Rao PN, Gupta R, Reddy DN. Acute on chronic liver failure-in-hospital predictors of mortality in ICU. J Clin Exp Hepatol. 2018;8:144–55. doi:10.1016/j.jceh.2017.11.008.
   PubMed Web of Science ®Google Scholar
• Dhotial A, Kapoor D, Kumar N. Seroprevalence of hepatitis A virus antibody in patients with chronic liver disease - experience from a tertiary care hospital in north India. Trop Gastroenterol. 2002;23:170–71.
   PubMedGoogle Scholar
• Duseja A, Sharma S, Das K, Dhiman RK, Chawla YK. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver? Trop Gastroenterol. 2004;25:162–63.
   PubMedGoogle Scholar
• John A, Chatni S, Narayanan VA, Balakrishnan V, Nair P. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy. J Indian Med Assoc. 2009;107:859–61.
   PubMedGoogle Scholar
• Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID 3rd, Hale EC, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127:817–26. doi:10.1542/peds.2010-2217.
   PubMed Web of Science ®Google Scholar
• Khanna S, Vohra P, Jyoti R, Vij JC, Kumar A, Singal D, Tandon R. Changing epidemiology of acute hepatitis in a tertiary care hospital in Northern India. Indian J Gastroenterol. 2006;25:101–02.
   PubMedGoogle Scholar
• Advisory Committee on Vaccines & Immunization Practices (ACVIP). IAP guidebook on immunization 2018-2019. Balasubramanian S, Shastri DD, Shah AK, Chatterjee P, Pemde HK, Shivananda S, Guduru VK. eds.  New Delhi (India): Jaypee Brothers Medical Publishers (P) Ltd.; 2020.
   Google Scholar
• Agrawal A, Singh S, Kolhapure S, Hoet B, Arankalle V, Mitra M. Increasing burden of hepatitis A in adolescents and adults and the need for long-term protection: a review from the Indian subcontinent. Infect Dis Ther. 2019;8:483–97. doi:10.1007/s40121-019-00270-9.
   PubMed Web of Science ®Google Scholar
• Lee HW, Chang DY, Moon HJ, Chang HY, Shin EC, Lee JS, Kim KA, Kim HJ. Clinical factors and viral load influencing severity of acute hepatitis A. PLoS One. 2015;10:e0130728. doi:10.1371/journal.pone.0130728.
   PubMed Web of Science ®Google Scholar
• Poddar U, Ravindranath A. Is time ripe for hepatitis A mass vaccination? Indian Pediatr. 2019;56:731–32. doi:10.1007/s13312-019-1630-3.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488–96. doi:10.1097/QCO.0000000000000188.
   PubMed Web of Science ®Google Scholar
• Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP, Gandhe SS. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). J Viral Hepat. 2001;8:293–303. doi:10.1046/j.1365-2893.2001.00279.x.
   PubMed Web of Science ®Google Scholar
• Das K, Jain A, Gupta S, Kapoor S, Gupta RK, Chakravorty A, Kar P. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol. 2000;16:507–10. doi:10.1023/a:1007628021661.
   PubMed Web of Science ®Google Scholar
• Gadgil PS, Fadnis RS, Joshi MS, Rao PS, Chitambar SD. Seroepidemiology of hepatitis A in voluntary blood donors from Pune, Western India (2002 and 2004-2005). Epidemiol Infect. 2008;136:406–09. doi:10.1017/S0950268807008643.
   PubMed Web of Science ®Google Scholar
• Arankalle V, Tiraki D, Kulkarni R, Palkar S, Malshe N, Lalwani S, Mishra A. Age-stratified anti-HAV positivity in Pune, India after two decades: has voluntary vaccination impacted overall exposure to HAV? J Viral Hepat. 2019;26:757–60. doi:10.1111/jvh.13074.
   PubMed Web of Science ®Google Scholar
• Arankalle VA, Tsarev SA, Chadha MS, Alling DW, Emerson SU, Banerjee K, Purcell RH. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995;171:447–50. doi:10.1093/infdis/171.2.447.
   PubMed Web of Science ®Google Scholar
• Deoshatwar AR, Gurav YK, Lole KS. Declining trends in Hepatitis A seroprevalence over the past two decades, 1998-2017, in Pune, Western India. Epidemiol Infect. 2020;148:e121. doi:10.1017/S0950268820000953.
   PubMed Web of Science ®Google Scholar
• Acharya SK, Batra Y, Bhatkal B, Ojha B, Kaur K, Hazari S, Saraya A, Panda SK. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol. 2003;18:822–27. doi:10.1046/j.1440-1746.2003.03051.x.
   PubMed Web of Science ®Google Scholar
• Kumar S, Ratho RK, Chawla YK, Chakraborti A. The incidence of sporadic viral hepatitis in North India: a preliminary study. Hepatobiliary Pancreat Dis Int. 2007;6:596–99.
   PubMed Web of Science ®Google Scholar
• Irshad M, Singh S, Joshi YK Viral hepatitis in India: a report from Delhi. Glob J Health Sci 2010; 2:96–103.
   Google Scholar
• Jain P, Prakash S, Gupta S, Singh KP, Shrivastava S, Singh DD, Singh J, Jain A. Prevalence of hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus and hepatitis E virus as causes of acute viral hepatitis in North India: a hospital based study. Indian J Med Microbiol. 2013;31:261–65. doi:10.4103/0255-0857.115631.
   PubMed Web of Science ®Google Scholar
• Tewari R, Makeeja V, Dudeja M. Prevalence of hepatitis A in southern part of Delhi, India. Int J Med Sci Public Health. 2016;5:2067–70. doi:10.5455/ijmsph.2016.20112015426.
   Google Scholar
• Sharma AK, Dutta U, Sinha SK, Kochhar R. Upsurge in vaccine preventable hepatitis A virus infection in adult patients from a tertiary care hospital of North India. Poster presentated at the 17th International Congress on Infectious Diseases. Int J Infect Dis. abstract 43.233]. Available at https://www.researchgate.net/publication/299473755_Upsurge_in_vaccine_preventable_hepatitis_A_virus_infection_in_adult_patients_from_a_tertiary_care_hospital_of_North_India, accessed. 2016;45S:457. April 23, 2020.
   Google Scholar
• Poddar U, Thapa BR, Prasad A, Singh K. Changing spectrum of sporadic acute viral hepatitis in Indian children. J Trop Pediatr. 2002;48:210–13. doi:10.1093/tropej/48.4.210.
   PubMed Web of Science ®Google Scholar
• Mittal A, Bithu R, Vyas N, Maheshwari RK. Prevalence of hepatitis A virus and hepatitis E virus in the patients presenting with acute viral hepatitis at a tertiary care hospital Jaipur Rajasthan. N Niger J Clin Res. 2016;5:47–50. doi:10.4103/2250-9658.197436.
   Google Scholar
• National Health Portal (NHP) India. Universal immunisation programme. Available at https://www.nhp.gov.in/universal-immunisation-programme_pg, accessed June 5, 2020.
   Google Scholar
• National Centre for Disease Control. Viral hepatitis: the silent disease facts and treatment guidelines. Available at https://ncdc.gov.in/linkimages/guideline_hep20158117187417.pdf, accessed April 30, 2020.
   Google Scholar
• Expert Group of the Association of Physicians of India on Adult Immunization in India. Executive summary: the association of physicians of India evidence-based clinical practice guidelines on adult immunization. J Assoc Physicians India 2009;57:345–56.
   PubMedGoogle Scholar
• Indian Society of Nephrology. Indian Society of Nephrology guidelines for vaccination in chronic kidney disease. Indian J Nephrol. 2016;26(Suppl1):S1–S30.
   PubMedGoogle Scholar
• Indian Medical Association. Life course immunization guidebook. A quick reference guide. Available at http://www.ima-india.org/ima/pdfdata/IMA_LifeCourse_Immunization_Guide_2018_DEC21.pdf, accessed April 5, 2019.
   Google Scholar
• Sri Lanka Medical Association (SLMA). SLMA guidelines and information on vaccines. Available at https://slma.lk/wp-content/uploads/2017/12/GSK-SLMA-Guidelines-Information-on-Vaccines.pdf, accessed June 9, 2020.
   Google Scholar
• Chitambar SD, Chadha MS, Joshi MS, Arankalle VA. Prevalence of hepatitis A antibodies in western Indian population: changing pattern. Southeast Asian J Trop Med Public Health. 1999;30:273–76.
   PubMedGoogle Scholar
• Waghray A, Waghray N, Khallafi H, Menon KV. Vaccinating adult patients with cirrhosis: trends over a decade in the United States. Gastroenterol Res Pract. 2016;2016:5795712. doi:10.1155/2016/5795712.
   PubMed Web of Science ®Google Scholar